银发经济或成下一个风口(共8份)
银发经济或成下一个风口
-
艾媒咨询|2024年中国养生茶饮行业现状研究及消费者洞察报告
国民健康需求的升级、养生文化的盛行、国家政策的支持与法令法规的准允,为药食同源产业的蓬勃发展提供了有力保障,也为养生茶饮的市场扩容注入了强劲动力。养生茶饮作为健康食疗的一种,结合了拥有数千年的历史底蕴与广大的群众基础的传统中医养生文化,被赋予着“寓医于食”的温和而个性化的天然优势。随着现代生活节奏加快和健康观念普及,养生茶饮成为了健康生活的新宠。全球新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询)最新发布的《2024年中国养生茶饮行业现状研究及消费者洞察报告》数据显示,2023年中国养生茶饮市场规模为411.6亿元,同比增长27.3%;预计2028年将突破千亿元。超九成消费者在每月养生茶饮的消费支出上超过了50元,而消费者消费养生茶饮时最重视的因素为口感与口味,其比例为65.2%。在消费群体年轻化已成趋势、健康理念成消费升级新需求的大背景下,养生茶饮企业需加强产品创新与技术升级为产业提质升级,并扩宽渠道可能,同时努力开拓年轻化的健康消费市场,创新传承中医养生文化来迎合市场需求,方可扩大市场影响力,抓住赛道机遇。
The enhancement of national healthcare needs, the promotion of health culture, the backing of national policies and the enactment of laws and regulations provide a robust assurance for the dynamic growth of the pharmaceutical and food industry, as well as inject a powerful impetus for the market expansion of healthy herbal beverage industry. Healthy herbal beverage, as a form of nutritious diet, integrates traditional Chinese medicine health culture with millennia-old history and broad public support, and is endowed with the gentle and personalized natural advantages of "integrating medicine into food". With the accelerated pace of modern life and widespread adoption of health concepts, healthy herbal beverage has emerged as a new favorite in healthy living.According to the latest Research Report 2024 China Health Herbal Beverage Industry Status Research and Consumer Insight Report released by iiMedia Research, a third-party data mining and analysis institution of the global new economy industry, China's healthy herbal beverage market size is projected to reach 41.16 billion yuan by 2023, representing a 27.3% increase. It is expected to surpass 100 billion yuan by 2028. Over 90% consumers spend more than 50 yuan per month on healthy herbal beverages, with taste being cited as the most important factor at 65.2%. Against this backdrop where younger consumer groups are gaining prominence and wellness concepts are driving consumption upgrades, healthy herbal beverage companies need to bolster product innovation and technological advancement to enhance quality while expanding potential channels. Simultaneously they should strive to tap into the younger demographic's interest in wellness products through innovative approaches that uphold traditional Chinese medicine culture in order to meet market demand effectively expand their influence. -
艾媒咨询|2024-2025年中国头皮疗养行业发展趋势分析报告
随着现代生活节奏加快、压力增大,头皮问题逐渐增多,消费者对于头皮疗养产品的需求日益增长。全球新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询)最新发布的《2024-2025年中国头皮疗养行业发展趋势分析报告》数据显示,2023年中国护发产品市场规模达到620.90亿元,同比增长3.4%,预计2025年将达691.07亿元。随着居民对头皮健康问题的日益重视,头皮疗养行业有望得到新的发展。
With the acceleration of the pace of modern life and the increase of pressure, scalp problems are gradually increasing, and the demand of consumers for scalp therapy products is growing. According to the latest "Analysis report on the development trend of China's scalp therapy industry from 2024 to 2025" released by iiMedia Research, a third-party data mining and analysis institution in the global new economy industry, the market size of China's hair care products will reach 62.09 billion yuan in 2023, an increase of 3.4%. It is expected to reach 69.11 billion yuan by 2025. With the increasing attention of residents to scalp health problems, scalp therapy industry is expected to get new development. -
艾媒咨询|2020年第三季度中国中药材行业数据监测季度报告
本报告研究涉及企业/品牌/案例:同仁堂、香雪制药、白云山。
数据显示,2020年第三季度,中药材价格指数迎来上涨周期。艾媒咨询分析师认为,受动物类等少数品种拉动影响,预计2020年10-11月中药材指数会持续走高,但是在12月维稳。据调查,绝大多数商户将会在2021年密切关注行业相关政策、谨慎经营,采取减少压货炒作等经营方式。因而,预计中药材市场在2020年末旺季会有一波行情的走高,但随着旺季结束,明年年初的价格会重新回落,随着疫情的常态化,中药材市场行情预期会呈周期性波动的态势。
Data show that in the third quarter of 2020, Chinese Herbal Medicine Price Index ushered in an upward cycle. iiMedia Research believe that by a small number of animals and other species pull the impact of October 2020-november Chinese herbal medicine index is expected to continue to rise, but stable in December. According to the survey, the vast majority of businesses in the 2021 will pay close attention to industry-related policies, prudent management, to reduce speculation and other business practices. As a result, the Chinese herbal medicine market is expected to see a wave of rising prices in the peak season at the end of 2020. However, as the peak season ends, prices will fall back early next year, and as the epidemic becomes more normal, chinese medicinal materials market is expected to be cyclical fluctuations in the situation. -
艾媒咨询|2021全球与中国医药电商市场与发展趋势研究报告
本报告研究涉及企业/品牌/案例:阿里健康,美团,京东健康,叮当快药,1药网,Walgreens,百度健康,药材买卖网,中药材天地网,找药网,九州通,药易购,珍诚医药在线,CVS
在政策利好、互联网技术等多重因素推动下,中国医药电商行业规模持续快速发展,2020年中国医药电商市场交易规模达到1956亿元。当前,中药电商商业模式主要为B2B、B2C、O2O与DTP四种类型,其中,2020年,医药电商B2C模式占比近6%,市场规模为116亿元;医药电商B2C模式占比近84%,市场规模为1640亿元,成为当前的主流。此外,近几年兴起的O2O模式,主要通过“引流-转化-消费-反馈”等实现盈利,而DTP药房模式下,患者在医院开取处方后,药房根据处方以患者或家属指定的时间和地点送药上门,被称为高值新特药直送平台。
Driven by favorable policies, Internet technology and other factors, the scale of China's pharmaceutical e-commerce industry continues to develop rapidly, with the transaction scale of China's pharmaceutical e-commerce market reaching 1956 billion yuan in 2020. At present, the business models of traditional Chinese medicine e-commerce are mainly B2B, B2C, o2o and DTP. In 2020, the B2C model of pharmaceutical e-commerce accounts for nearly 6% and the market scale is 11.6 billion yuan; the B2C model of pharmaceutical e-commerce accounts for nearly 84% and the market scale is 164 billion yuan, which has become the current mainstream. In addition, the o2o mode, which has sprung up in recent years, mainly achieves profits through "drainage transformation consumption feedback". In the DTP pharmacy mode, after patients get prescriptions in the hospital, the pharmacy delivers drugs to the door at the time and place designated by the patients or their families according to the prescriptions, which is known as the high value new special drugs direct delivery platform. -
艾媒咨询|2020Q2中国中药材行业季度数据监测报告
本报告研究涉及企业/品牌/案例:云南白药,天士力。
数据显示,2020年4-5月中药材价格指数小幅下降,行情总体较为震荡。艾媒咨询分析师认为,自第二季度起中药材基本不受新冠肺炎疫情影响,市场秩序趋于稳定,但需求仍然不足,中药材基本以减产居多,减产的信号给予商家部分信心,一旦消费情况好转,中药材价格会重新上涨,因此商家谨慎投资与积极备货双管齐下,导致第二季度中药材大盘指数震荡。
Data show that the price index of Chinese medicinal materials declined slightly from April to May 2020, and the market was generally volatile. iiMedia Research believe that since the second quarter, Chinese herbal medicines have basically not been affected by the new coronary pneumonia epidemic. The market order has stabilized, but demand is still insufficient. Basically, Chinese herbal medicines basically reduce production. The signal of reduced production gives businesses some confidence. Once consumed The situation improves, and the prices of Chinese herbal medicines will rise again. Therefore, merchants' cautious investment and active inventory preparation have taken two measures, leading to the second quarter Chinese herbal medicines market index shock. -
艾媒报告|2019-2021年中国中药材用户调研及延伸市场研究报告
本报告研究涉及企业/品牌/案例:同仁堂,片仔癀,东阿阿胶,太极集团,胡庆余堂,同仁牛黄清心丸,黄芪颗粒,雷氏丹参片,云峰气血口服液,太极五子衍宗丸,太极生力雄丸,仲景左归丸,一笑堂龟甲壳,白云山复方丹参片,天士力养血清脑颗粒,白云山夏桑菊颗粒,白云山板蓝根颗粒
随着居民消费水平的提升和健康保健意识的增强,总体健康需求在扩大,进而推动中医药市场的发展,2018年中国中药材市场规模达1246亿元,同比增长22.40%,预计到2024年,中药材市场规模将达2004亿元。
iiMedia Research(艾媒咨询)调查显示,2019年接近五成受访者购买过中药材,滋补养生和治病是购买中药材的两大目的。由于中医药应用范围广泛,中医药产业链不断扩展延伸,并加速扩展和整合。同仁堂、片仔癀、东阿阿胶等中药巨头企业纷纷布局中药材后市场,建设中药大健康产业,如植物提取物、保健食品、中药化妆品等,已成为我国生命健康产业中最具成长性的组成部分。
According to the iiMedia Research survey, nearly 50% of respondents have bought Chinese herbal medicines in 2019, and tonic sage and cure are the two main purposes for buying Chinese herbal medicines. Due to the wide range of applications of Chinese medicine, the Chinese medicine industry chain continues to expand and expand and accelerate the expansion and integration. Tongrentang, tablets, Dong'a gum and other Chinese medicine giant enterprises have laid out the chinese medicine after the market, the construction of chinese medicine large health industry, such as plant extracts, health food, Chinese medicine cosmetics, etc., has become China's life and health industry in the most growth component.
(以下为节选页,完整版共88页)
- 1
- 2
没找到想要的报告?
扫码添加客服参与预约/定制,第一时间获取行业推荐报告!
智库热榜
艾媒咨询|2024-2025年中国银发经济投资前景分析报告
艾媒咨询|2024-2025年中国烘焙食品行业现状及趋势研究报告
艾媒咨询 | 2023-2024年中国休闲食品产业现状及消费行为数据研究报告
艾媒咨询|2024-2025年全球及中国新能源汽车行业消费趋势监测与案例研究报告
艾媒咨询 | 2023-2024年中国全域旅游产业运行数据及发展趋势研究报告
艾媒咨询 | 2024年中国家用美容仪行业消费者洞察研究报告
艾媒咨询|赵一鸣零食店消费行为洞察及行业趋势报告(2024)
艾媒咨询|2024年中国月饼行业创新发展研究报告
艾媒咨询 | 2024年中国数字中台市场研究报告
艾媒咨询|2023-2024年全球及中国跨境电商运营数据及典型企业分析研究报告
艾媒咨询|2024年中国家清产品消费趋势洞察报告